Loading...
Repeated COVID-19 relapse during post-discharge surveillance with viral shedding lasting for 67 days in a recovered patient infected with SARS-CoV-2
Liu, Fang Cai, Zhao-bin Huang, Jin-song Niu, Hai-ying Yu, Wen-yan Zhang, Yan Yan, Ting-bo Chen, Chen Liu, Yuan Xu, Ai-fang
Liu, Fang
Cai, Zhao-bin
Huang, Jin-song
Niu, Hai-ying
Yu, Wen-yan
Zhang, Yan
Yan, Ting-bo
Chen, Chen
Liu, Yuan
Xu, Ai-fang
Citations
Altmetric:
Genre
Journal article
Date
2020-08-06
Advisor
Committee member
Group
Department
Neuroscience
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
https://doi.org/10.1016/j.jmii.2020.07.017
Abstract
A case who revealed the longest duration of viral shedding (67 days) in current reports, presented complicated characteristic on the relapse of COVID-19 due to the inconsistent performance of chest radiography and SARS-CoV-2-RNA detection after discharge. Lopinavir-interferon α2b boosted ribavirin following with lopinavir boosted budesonide might be a potent treatment for viral clearance.
Description
Citation
F. Liu, Z. Cai, J. Huang, et al. Repeated COVID-19 relapse during post-discharge surveillance with viral shedding lasting for 67 days in a recovered patient infected with SARS-CoV-2. Journal of Microbiology, Immunology and Infection (2020). https://doi.org/10.1016/j.jmii.2020.07.017
Citation to related work
Elsevier
Has part
Journal of Microbiology, Immunology and Infection
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu